Diagnostic Kits/Paper

From Commons Based Research
Jump to navigation Jump to search

Are patents clogging the pipeline: The effects of intellectual property on commercialization and access to genetic diagnostics
(A Summary Paper of our Research to date)
By Carolina Rossini, Andrew Clearwater, and Mackenzie Cowell

Last Draft: December 3, 2009

Introduction

Description of the GDx Market

Defining Genetic Diagnostics

from Educational_Materials#Field_Definition

Brief History of GDx and Related Technology

  • chemical patents at turn of century (see Palombi's work)

Overview of IP Landscape

from Overview_of_Economics_of_Intellectual_Property_in_Kits see overview]

Patent Protection

Bayh-Dole

Licensing

When IP Does and Does Not Work Effectively

Our Research Questions

Our Methodology

Forces affecting the GDx Industry

Revolutionary technical advances

Regulatory process

payer system (public & private insurance)

Intellectual Property

Case Law

Proposed Alternative Protection Schemes

  • Patent Pools
  • Patent Clearing Houses

Licensing

  • Licensing Approaches
  • Compulsory Licensing
  • Licensing Behavior

Existing and Evolving GDx Models

Commercialization of Basic Research

  • Licensing of research to existing GDx company
  • Licensing of research to new GDx start-up
  • Usage of research in public domain by existing GDx company? (multiplex kits?)

Paths to Market

  • ASRs
  • Kits
  • DTC

Discussion

Conclusions

Bibliography